The history of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in income, its patent expiration created a flood of knock-off medications, significantly diminishing its dominance. While some firms may attempt to capitalize on related treatments , the present land